FDA — authorised 19 March 2013
- Application: ANDA204054
- Marketing authorisation holder: LGM PHARMA
- Local brand name: MECAMYLAMINE HYDROCHLORIDE
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 MECAMYLAMINE HYDROCHLORIDE in United States
FDA authorised MECAMYLAMINE HYDROCHLORIDE on 19 March 2013
Marketing authorisations
FDA
- Status: approved
MECAMYLAMINE HYDROCHLORIDE in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is MECAMYLAMINE HYDROCHLORIDE approved in United States?
Yes. FDA authorised it on 19 March 2013; FDA has authorised it.
Who is the marketing authorisation holder for MECAMYLAMINE HYDROCHLORIDE in United States?
LGM PHARMA holds the US marketing authorisation.